In March and April 2018, we carried out a survey of myxosporean parasites in coastal fishes collected from Nha Trang Bay in Vietnam's East Sea. Of the 159 fish specimens, 18 fish species were represented, belonging to 10 families. In 8 host species, 7 myxosporean species were found, representing the genera Kudoa and Unicapsula. Two of these species were new to science: Kudoa igori n. sp. from the gallbladder of Longarm mullet Osteomugil cunnesius (Valenciennes, 1836) (prevalence 10%) and Kudoa borimiri n. sp. from skeletal muscles of Longarm mullet and Longfinned mullet Osteomugil perusii (Valenciennes, 1836) (prevalence 30% and 60%, respectively). Vegetative stages were not found. Spores of K. igori n. sp. were small, orbicular to quadrate in apical view, and with four equal valves. In lateral view, spores were shallowly ovoid with a slightly protruding anterior pole. The 4 polar capsules were slightly unequal sizes and were oriented toward the apex of the spore. Dimensions were as follows: spore length 4.56 ± 0.22 (4.18-4.56), thickness 4.42 ± 0.39 (3.55-5.13), width 5.74 ± 0.46 (4.66-6.50), length of biggest polar capsule 1.38 ± 0.14 (1.1-1.65), middle 1.28 ± 0.12 (1.03-1.53), smallest 1.13 ± 0.11 (0.94-1.30), width of biggest polar capsule 1.03 ± 0.14 (0.83-1.4), middle 0.92 ± 0.12 (0.76-1.08), smallest 0.74 ± 0.12 (0.55-0.94). Spores of K. borimiri n. sp. had four equal valves with slightly rounded ends and were quadrate in apical view. In lateral view, spores were broadly deltoid. Four equal-sized polar capsules opened at the apex of the spore. In O. cunnesius, spore dimensions were as follows: length 3.51 ± 0.15 (3.34-3.92), thickness 3.65 ± 0.38 (2.79-4.21), width 4.97 ± 0.37 (4.13-5.97), length of the polar capsules 1.23 ± 0.18 (0.99-1.57), width 0.88 ± 0.07 (0.70-1.00). Overlapping dimensions for K. borimiri n. sp. spores were also found in O. perusii. Other known myxozoan species we encountered were Kudoa thyrsites and Kudoa whippsi, which had not previously been reported from the East Sea and Vietnam. We also encountered Kudoa monodactyli, which had not previously been reported from Nha Trang Bay. In addition, we report 2 additional species, a Kudoa sp. and a Unicapsula sp., that were not attributable to previously described myxozoans and need further investigation to completely characterize.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00436-022-07620-6 | DOI Listing |
During surveys worldwide, we collected adult and larval specimens of Pseudopolydora Czerniavsky, 1881 similar to P. achaeta Radashevsky & Hsieh, 2000 and P. rosebelae Radashevsky & Migotto, 2009 far from their type localities in Taiwan and Brazil, respectively.
View Article and Find Full Text PDFPLoS One
December 2024
Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
Disease burden associated with cardiovascular diseases (CVDs) in low- and middle-income countries has been on an increasing trend in the past decades. Despite the worldwide genetic, cultural, and environmental variations in determinants of CVDs, few studies have attempted the identification of risk factors of CVDs in low- and middle-income countries. This article aims to introduce the Khánh Hòa Cardiovascular Study, a prospective cohort study among middle-aged community dwellers in rural Khánh Hòa, Vietnam.
View Article and Find Full Text PDFVaccine
January 2025
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA; Department of Medicine, University of California, San Diego, (UCSD), La Jolla, CA, 92037, USA. Electronic address:
Production of affordable coronavirus disease 2019 (COVID-19) vaccines in low- and lower-middle-income countries is needed. NDV-HXP-S is an inactivated egg-based recombinant Newcastle disease virus vaccine expressing the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A public sector manufacturer in Vietnam assessed the immunogenicity of NDV-HXP-S (COVIVAC) relative to an authorized vaccine.
View Article and Find Full Text PDFN Engl J Med
November 2024
From the Department of Pediatric Infectious Diseases, Institute of Tropical Medicine (L.-M.Y., M. Toizumi, C.I., M. Takegata), the Department of Global Health, School of Tropical Medicine and Global Health (L.-M.Y., M. Toizumi), and Nagasaki University Graduate School of Biomedical Science (L.-M.Y.), Nagasaki University, Nagasaki, and the National Institute of Infectious Diseases, Tokyo (N.K.) - both in Japan; the Department of Bacteriology, National Institute of Hygiene and Epidemiology, Hanoi (H.A.T.N., L.H.H., D.-A.D.), and the Department of Bacteriology, Pasteur Institute, Nha Trang (L.T.L., H.T.D.) - both in Vietnam; the Department of Infectious Disease Epidemiology (B.J.Q., K.Z., K.M., S.F.) and the Centre for Mathematical Modelling of Infectious Diseases (B.J.Q., K.Z., S.F.), London School of Hygiene and Tropical Medicine, and the Institute for Infection and Immunity, St. George's University (J.H.) - both in London; the Department of Infection, Immunity, and Global Health, Murdoch Children's Research Institute (M.L.N., B.D.O., E.M.D., C.S., K.M.), and the Department of Paediatrics, University of Melbourne (C.S., K.M.), Melbourne, VIC, and the Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC (C.S.) - all in Australia; and the Center for Global Health, Charité-Universitätmedizin Berlin, Berlin (S.F.).
Background: After pneumococcal disease and colonization have been controlled through vaccination campaigns, a reduced pneumococcal conjugate vaccine (PCV) schedule may be sufficient to sustain that control at reduced costs.
Methods: We investigated whether a single primary dose and booster dose (1p+1) of the 10-valent PCV (PCV10) would be noninferior to alternative dose schedules in sustaining control of carriage of pneumococcal serotypes included in the vaccine. In Nha Trang, Vietnam, an area in which PCV had not been used previously, a PCV10 catch-up campaign was conducted in which the vaccine was offered to children younger than 3 years of age, after which a cluster-randomized trial was conducted in which children received PCV10 at 2, 3, and 4 months of age (3p+0 group); at 2, 4, and 12 months of age (2p+1 group); at 2 and 12 months of age (1p+1 group); or at 12 months of age (0p+1 group).
ACS Appl Mater Interfaces
November 2024
Beamline Research Division, Pohang Accelerator Laboratory, POSTECH, Pohang 37673, Republic of Korea.
Understanding and controlling the oxidation of layered materials remain critical issues in the final stages of their practical application in devices. Layered materials achieve a band gap by removing inversion symmetry. However, the oxidation process becomes complex, and the oxidation of these materials is not yet fully understood.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!